cMYC expression in infiltrating gliomas: associations with IDH1 mutations, clinicopathologic features and outcome.

Yazmin Odia; Brent A. Orr; W. Robert Bell; Charles G. Eberhart; Fausto J. Rodriguez

doi:10.1007/s11060-013-1221-4

cMYC expression in infiltrating gliomas: associations with IDH1 mutations, clinicopathologic features and outcome.

Yazmin Odia, Brent A. Orr, W. Robert Bell, Charles G. Eberhart, Fausto J. Rodriguez

Miami Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Journal of neuro-oncology
Volume	115
DOIs	https://doi.org/10.1007/s11060-013-1221-4
State	Published - Jan 11 2013

Disciplines

Biology
Oncology
Genetics
Pathology

Access to Document

10.1007/s11060-013-1221-4License: Unspecified

Cite this

@article{7182a53cbf8647dca1a3793f20f9dd02,

title = "cMYC expression in infiltrating gliomas: associations with IDH1 mutations, clinicopathologic features and outcome.",

author = "Yazmin Odia and Orr, {Brent A.} and Bell, {W. Robert} and Eberhart, {Charles G.} and Rodriguez, {Fausto J.}",

note = "Gliomas are among the most frequent adult primary brain tumors. Mutations in IDH1, a metabolic enzyme, strongly correlate with secondary glioblastomas and increased survival. cMYC is an oncogene also implicated in aberrant metabolism, but its prognostic impact remains unclear.",

year = "2013",

month = jan,

day = "11",

doi = "10.1007/s11060-013-1221-4",

language = "American English",

volume = "115",

journal = "Journal of neuro-oncology",

}

TY - JOUR

T1 - cMYC expression in infiltrating gliomas: associations with IDH1 mutations, clinicopathologic features and outcome.

AU - Odia, Yazmin

AU - Orr, Brent A.

AU - Bell, W. Robert

AU - Eberhart, Charles G.

AU - Rodriguez, Fausto J.

N1 - Gliomas are among the most frequent adult primary brain tumors. Mutations in IDH1, a metabolic enzyme, strongly correlate with secondary glioblastomas and increased survival. cMYC is an oncogene also implicated in aberrant metabolism, but its prognostic impact remains unclear.

PY - 2013/1/11

Y1 - 2013/1/11

UR - https://link.springer.com/content/pdf/10.1007%2Fs11060-013-1221-4.pdf

U2 - 10.1007/s11060-013-1221-4

DO - 10.1007/s11060-013-1221-4

M3 - Article

VL - 115

JO - Journal of neuro-oncology

JF - Journal of neuro-oncology

ER -

cMYC expression in infiltrating gliomas: associations with IDH1 mutations, clinicopathologic features and outcome.

Disciplines

Access to Document

Other files and links

Cite this